key: cord-0289784-hkpnfbpi
authors: Ghosh, Arup; Bal, Himadri; Biswas, Viplov Kumar; Das, Dasarathi; Pati, Sanghmitra; Raghav, Sunil
title: Genotypic and phenotypic diversity of the multidrug-resistant Mycobacterium tuberculosis strains from eastern India
date: 2022-04-11
journal: bioRxiv
DOI: 10.1101/2022.04.11.487831
sha: 4dab0954a14297c4227c5ad0913b8d49b3b07bb5
doc_id: 289784
cord_uid: hkpnfbpi

Mycobacterium tuberculosis (Mtb) poses a great challenge to human health and wellbeing and hinders economic growth of a region. India along with other south east Asian countries are known as high Tuberculosis burden countries. Adoption of whole genome sequencing in studying genetic diversity, evolution, transmission pattern and drug resistance development provided a great opportunity for developing and improving diagnostic and therapeutic approaches. In our study we have sequenced 118 Mtb whole genome from North East(NE) and Odisha as a representative of the diversity in eastern region of India for the first time. We observed high prevalence of multi-drug resistant(MDR) lineage-2(n=52) strains in NE whereas presence of mostly lineage-1(n=30) & 3 (n=11) strains in Odisha. The MDR strains from Sikkim demonstrated similar resistance profile of fluroquinolones and pair-wise SNP distances showed presence of local transmission clusters. We also detected significant enrichment of short INDELs in MDR samples in contrast to drug susceptible samples. This study provides molecular level insight into Mtb strains of eastern region in comparison with Indian and global perspective.

Tuberculosis Report 2020 states that 26% of new TB cases are from India, which is the 44 highest number among high TB burden countries followed by China with 9% of new cases 45 reported. Although the number of new cases globally was lower than the 2017 report, there 46 was only a marginal change observed in new cases from India(2). Also, India has the 47 second-highest incidence of multidrug resistance (MDR) cases with the highest mortality rate 48

(2). Although the drug-susceptible cases had a higher treatment success rate, the MDR and 49 XDR TB cases had a treatment success rate of only 54% and 30%, respectively (3). The 50 major challenge with the current TB diagnostic strategies are the time required for culture-51 based tests (3-6 weeks) and commercially available molecular diagnostics fail to account for 52 novel compensatory mutations leading to drug resistance development (4, 5). 53

From the previous whole-genome sequencing reports and molecular dating (spoligotyping) 54 studies it has been observed that the northern part of India is dominated by Lineage-3 55 whereas southern states show a prevalence of Lineage-1, central India has the presence of 56 CAS & EAI, eastern states show a mixed diversity of lineage and the north-eastern states 57 has a very dominant presence of Beijing lineage (6-9). 58

A genome-wide analysis study as a part of TB-ARC India project first time shed light on the 59 lesser-known genetic diversity of the Mtb strains in the southern part of India (5). This study 60 was conducted using 223 clinical isolates of which ~15% strains were resistant for at least 61 one drug when determined using phenotypic and genotypic drug susceptibility testing (DST) 62 methods. In other studies, also where a lesser number of drug-resistant strains were 63 investigated, the commercially available tests failed to detect the novel mutations present in 64

Indian strains thereby resulting in a false negative outcome (6). A whole-genome study from 65

The Foundation for Medical Research Mumbai also demonstrated the occurrence of novel Mycobacterium tuberculosis (Mtb) whole-genome sequences from ICMR-Jalma consisting of 68 91 MDR samples collected from north India identified novel resistance-associated mutations 69 that are not used in any available molecular detection tests (7). 70

Whole-genome sequencing in recent times has provided us with a better understanding of 71 drug resistance phenotypes and genomic diversity of Mtb globally (10, 11). Prediction of 72 phenotype resistance utilizing genomic variants for some of the first-line drugs and widely 73 used second-line drugs have shown promising results (12) (13) (14) limited number of drugs were tested for DST but with the help of whole-genome sequencing 210 data, we predicted the phenotypes for 11 drugs used for the treatment of tuberculosis. We 211 observed a high prevalence of rifampicin resistance followed by isoniazid, ethambutol, 212 streptomycin, and fluoroquinolone group of drugs in Sikkim. On the other hand in Odisha 213 isoniazid resistance is more prominent in comparison to other groups of drugs. 214 In-host pathogen dynamics in contrast to resistance-associated loci 242

During the process of samples collection we also followed up with six patients from Sikkim. 243

We collected a total of 7 isolates from five patients in an interval of 10 days to 1. 

Whole genome sequencing of Mycobacterium 465 tuberculosis clinical isolates from India reveals genetic heterogeneity and region-466 specific variations that might affect drug susceptibility

Whole genome 468 sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A 469 potential tool for determining drug-resistance and strain lineage

Genetic 474 diversity and drug susceptibility profile of Mycobacterium tuberculosis isolated from 475 different regions of India

Genome-wide analysis of multi-and extensively drug-484 resistant Mycobacterium tuberculosis

Harris migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern 489 humans

Beyond multidrug resistance: Leveraging rare variants with machine 492 and statistical learning models in Mycobacterium tuberculosis resistance prediction

Machine learning for classifying tuberculosis 496 drug-resistance from DNA sequencing data

DeepAMR for predicting co-occurrent 499 resistance of Mycobacterium tuberculosis

Whole genome 501 sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A 502 potential tool for determining drug-resistance and strain lineage

Predominance of ancestral lineages of

Mycobacterium tuberculosis in India

Compensatory evolution drives multidrug-resistant tuberculosis in central Asia

Central India: 573 evidences for action

In-host population dynamics of Mycobacterium 576 tuberculosis complex during active disease. Elife 10

Aligning sequence reads, clone sequences and assembly contigs with 578 BWA-MEM. 579 34

Pilon: An integrated tool for comprehensive 581 microbial variant detection and genome assembly improvement

Twelve years of SAMtools and 584

Ruden 586 DM. 2012. A program for annotating and predicting the effects of single nucleotide 587 polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain 588 w1118

Using 590

Drosophila melanogaster as a model for genotoxic chemical mutational studies with a 591 new program

SpoTyping: fast and accurate in silico

BEDTools: A flexible suite of utilities for comparing 595 genomic features

ModelFinder: fast model selection for accurate phylogenetic estimates

Improving the Ultrafast Bootstrap Approximation

Supplementary Figure 2 A) Hierarchical clustering of pair-wise SNP distances annotated 637 with lineage state and drug resistance phenotypes